SARAH BIER: Open Payments
NPI 1962920884 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,350 in 106 payments from 13 companies in 2025. Trend: 2023 $1,309 · 2024 $2,871 · 2025 $2,350
Food & beverage: $2,127Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $498 |
| Axsome Therapeutics, Inc. | 13 | $260 |
| ABBVIE INC. | 7 | $246 |
| E.R. Squibb & Sons, L.L.C. | 15 | $236 |
| Alkermes, Inc. | 12 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $206 |
| Lundbeck LLC | 12 | $203 |
| Neurocrine BioSciences, Inc. | 6 | $157 |
| Vanda Pharmaceuticals Inc. | 5 | $115 |
| Bausch Health US, LLC | 4 | $73 |
Products named: Auvelity, VRAYLAR, ARISTADA, CAPLYTA, COBENFY, INGREZZA, AUSTEDO XR, UZEDY.
Industry payments across IL — which companies pay providers there.
